BioNTech Shares Leap 4.3% Premarket: Earnings Decline Yet Surpass Estimates – Investors Celebrate!
BioNTech SE’s stock witnessed a 4.3% rise in pre-market trade on Monday after the German biotech firm posted stronger-than-expected first-quarter earnings. However, this was accompanied by a decrease in profit and revenue due to lower demand for the COVID vaccine, which BioNTech co-developed with Pfizer Inc. Based in Mainz, BioNTech reported a net profit of […]